Graham FOSTER
UK
Contact: g.r.foster@qmul.ac.uk
PHC's participations
Monday, January 30th 2017
LUNCH WORKSHOPS - 2-How to optimize treatment in G3 patients (chairman)
AROUND THE WORLD TABLE: ACCESS TO THERAPY - WESTERN COUNTRIES
Tuesday, January 31st 2017
TWO PROGRAMS OF HCV ERADICATION (chairman)
Monday, January 11th 2016
Individual optimization of therapy (shorten therapy) -
How to improve access to therapy? Around the World table - NORTH & WEST -
Lunch Workshops - Room 242A (chairman)
Monday, January 12th 2015
Why genotype 3 is difficult to cure? -
Monday, January 13th 2014
Personalized treatment with telaprevir -
How to optimize current therapy of non G1 patients (chairman)
Monday, January 14th 2013
Genotype 3 -
Interactive luncheons - Room 3 (chairman)
Controversy: F1/F2 patients: treat or wait? (chairman)
Monday, January 30th 2012
Interactive luncheons - Room 3 (chairman)
Interactive luncheons - Room 3 -
Genotype 3 -
Tuesday, January 31st 2012
Lead in or no lead in ? (chairman) -
Monday, January 19th 2009
Optimizing therapy in real life illustrated with clinical cases (chairman)
Monday, January 30th 2017
LUNCH WORKSHOPS - 2-How to optimize treatment in G3 patients (chairman)
AROUND THE WORLD TABLE: ACCESS TO THERAPY - WESTERN COUNTRIES -
Tuesday, January 31st 2017
TWO PROGRAMS OF HCV ERADICATION (chairman)
Monday, January 15th 2018
Cost benefit of treatment in F1 patients -
Luncheon workshops - (chairman)
- Speakers: (chairman)
Monday, January 14th 2019
not defined (chairman)
